Presented by
David L. Morgan, MD
Medical Director (Houston, Texas)
and Hematopathologist

Date: Wednesday, May 2, 2018
Time: 2 PM to 3 PM ET (11 AM to Noon PT)

Objectives

• Review morphologic changes associated with myelodysplasia, and their differential diagnosis.
• Discuss flow cytometry findings associated with myelodysplasia.
• Understand the prognostic significance of cytogenetic abnormalities in myelodysplasia.
• Appreciate the role of molecular analysis in the diagnosis of myelodysplasia.

About Dr. David L. Morgan
Medical Director (Houston, Texas) and Hematopathologist

Prior to joining NeoGenomics in 2016, Dr. Morgan served as the Medical Director of Flow Cytometry at Pathologists Bio-Medical/medfusion Laboratories in Texas. Prior to this position, Dr. Morgan was Medical Director of Hematopathology at AmeriPath North Texas from 2005 to 2010. From 1996 to 2005, Dr. Morgan occupied multiple positions at Texas Tech University Health Sciences Center, including Director of Hematopathology and Flow Cytometry, and Coordinator of the Pathology Residency Program. Dr. Morgan was a tenured Professor of Anatomic and Clinical Pathology at the time of leaving Texas Tech University. He obtained his medical degree from the University of Texas Southwestern Medical School in 1982. His residency in Anatomic and Clinical Pathology was at Presbyterian/St. Luke's Medical Center in Denver, Colorado. Dr. Morgan is a Fellow of the College of American Pathologists and the American Society for Clinical Pathology.